13C-Spirulina Nitrogen Content GEBT Study - Trial NCT04635306
Access comprehensive clinical trial information for NCT04635306 through Pure Global AI's free database. This phase not specified trial is sponsored by Cairn Diagnostics and is currently Terminated. The study focuses on Gastroparesis. Target enrollment is 12 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Cairn Diagnostics
Timeline & Enrollment
N/A
Oct 21, 2020
Jun 25, 2021
Primary Outcome
Difference in vivo 13C-Spirulina GEBT response
Summary
The purpose of this study is to determine whether there is a difference in the human in vivo
 response to 13C-Spirulina meals manufactured using 13C-Spirulina containing different levels
 of protein (as measured by %nitrogen).
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT04635306
Non-Device Trial